Forus

Last night we hosted a housewarming for our new office on Wooster St in SoHo. We had ~200 friends of @forus join us to celebrate, including many already interviewing, others just starting to look around, and former founders figuring out what’s next. Forus is at a true inflection point, rapidly expanding across the country to serve partners ranging from pediatric cancer wards to the fastest growing biotechs. We are limited only by capacity to take on the unprecedented opportunity in front of us. We are looking for high horsepower and hyper resourceful doers who can drive new customers, markets, and products. If you want to help us accelerate a new era of American medicine, please get in touch or come to our next house party (soon!)

.@nextplayso spoke with our engineers about the agents we’re building, the pace of the team, direct feedback, and the patients affected by what we get right or wrong. Thanks to @benln for putting together: Should you join @forus? nextplayso.substack.com/p/sh…

Last week our rep from @tryramp dropped off a 40" pair of red-handled scissors with the @forus logo on the blade. They are very sharp. Day ones know we originally incorporated as Red Scissor, Inc. (to cut through red tape for our users), and I still use my original Ramp card from before our name change. Such a fun gift, going on our office wall!

We weren’t planning to raise our Series C. The business was expanding faster than we could build capacity, and our investors saw it firsthand. They responded with more capital to help us scale the network faster. That speed matters beyond meeting demand, though. We recently met a 50-provider urology group that had stopped treating certain cancers because getting patients on prescribed therapies had become operationally unsustainable. At a critical point in their diagnosis, patients were turned away and left to find another specialist, potentially hours away, creating delays and increasing the risk that treatment never begins. Forus automates the process between prescription and treatment so practices can continue treating patients with the most serious conditions. I joined @KristenScholer on @NYSE Live to talk about why expanding the network faster matters.

Some companies start earning revenue the week they launch. The companies @MattHdeJonge and I chose to build required multiple years of work before the first dollar. This week, we were at MIT and Harvard to talk about why we started our companies and chose to build them this way. Applying AI to consequential problems requires understanding and rebuilding the full stack, not putting a model behind an existing workflow. For @fortellresearch, that meant years of R&D. For @forus, it meant solving a chicken-and-egg network across doctors, patients, and biopharma before the business model could prove itself. Investors like @ThriveCapital gave us the capital and credibility to pursue problems that would take years to solve but could produce an enormous payoff for society. The conversation ultimately came back to students asking which problems are worth spending years of your life solving. Matt captured that choice with the question that pushed him to leave Bridgewater: “If I were given a terminal diagnosis tomorrow, would I feel proud of how I had spent my time on earth?”